Advanced search
Publication Cover
Infection and Drug Resistance Volume 15, 2022 - Issue
Submit an article Journal homepage
492
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Impacts of Corticosteroid Therapy at Acute Stage of Hospital-Onset Clostridioides difficile Infections

Ching-Chi Lee1 Clinical Medicine Research Center, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, 704, Taiwan;2 Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, 704, TaiwanORCID Iconhttps://orcid.org/0000-0002-4949-2742View further author information
ORCID Icon,
Jen-Chieh Lee2 Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, 704, TaiwanView further author information
,
Chun-Wei Chiu3 Department of Internal Medicine, Tainan Hospital, Ministry of Health and Welfare, Tainan, 700, TaiwanView further author information
,
Pei-Jane Tsai4 Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, 704, Taiwan;5 Department of Pathology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan;6 Centers of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, TaiwanView further author information
,
Wen-Chien Ko2 Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, 704, Taiwan;7 Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, 704, TaiwanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7497-149XView further author information
ORCID Icon &
Yuan-Pin Hung2 Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, 704, Taiwan;3 Department of Internal Medicine, Tainan Hospital, Ministry of Health and Welfare, Tainan, 700, Taiwan;7 Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, 704, Taiwan;8 Department of Microbiology & Immunology, College of Medicine, National Cheng Kung University, Tainan, TaiwanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1006-705XView further author information
ORCID Icon
Pages 5387-5396 | Published online: 10 Sep 2022

References

  • Hung YP, Tsai CS, Tsai BY, et al. Clostridioides difficile infection in patients with hematological malignancy: a multicenter study in Taiwan. J Microbiol Immunol Infect. 2021;54(6):1101–1110. doi:10.1016/j.jmii.2021.02.002
  • Chiu CW, Tsai PJ, Lee CC, et al. Inhibition of spores to prevent the recurrence of Clostridioides difficile infection - A possibility or an improbability? J Microbiol Immunol Infect. 2021;54(6):1011–1017. doi:10.1016/j.jmii.2021.06.002
  • Lee CC, Lee JC, Chiu CW, et al. Clinical significance of toxigenic Clostridioides difficile growth in stool cultures during the era of nonculture methods for the diagnosis of C. difficile infection. Microbiol Spectr. 2021;9(2):e0079921.
  • Lai YH, Tsai BY, Hsu CY, et al. The role of Toll-Like receptor-2 in Clostridioides difficile infection: evidence from a mouse model and clinical patients. Front Immunol. 2021;12:691039.
  • DuPont HL, Garey K, Caeiro JP, Jiang ZD. New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and control. Curr Opin Infect Dis. 2008;21(5):500–507.
  • Messick CA, Hammel JP, Hull T. Risk factors that predict recurrent Clostridium difficile infections in surgical patients. Am Surg. 2017;83(6):653–659.
  • Eyre DW, Griffiths D, Vaughan A, et al. Asymptomatic Clostridium difficile colonisation and onward transmission. PLoS One. 2013;8(11):e78445.
  • Brown RJ, Raabe M, McCullough LD, Zhu L, Chokshi RV. Clostridium difficile infection does not impact outcomes in stroke patients. Neurologist. 2021;27(3):125–129.
  • Morales-Marroquin E, Xie L, Uppuluri M, Almandoz JP, Cruz-Munoz N, Messiah SE. Immunosuppression and Clostridioides (Clostridium) difficile infection risk in metabolic and bariatric surgery patients. J Am Coll Surg. 2021;233(2):223–231.
  • Viladomiu M, Hontecillas R, Pedragosa M, et al. Modeling the role of peroxisome proliferator-activated receptor γ and MicroRNA-146 in mucosal immune responses to Clostridium difficile. PLoS One. 2012;7(10):e47525. doi:10.1371/journal.pone.0047525
  • Donlan A, Petri WA Jr. The inflammasome and type-2 immunity in Clostridium difficile infection. Clin Colon Rectal Surg. 2020;33(2):67–72.
  • Ng J, Hirota SA, Gross O, et al. Clostridium difficile toxin-induced inflammation and intestinal injury are mediated by the inflammasome. Gastroenterology. 2010;139(2):542–52 e1-3.
  • Loo VG, Bourgault AM, Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med. 2011;365(18):1693–1703.
  • Hung YP, Cia CT, Tsai BY, et al. The first case of severe Clostridium difficile ribotype 027 infection in Taiwan. J Infect. 2015;70(1):98–101.
  • Skribek M, Rounis K, Afshar S, et al. Effect of corticosteroids on the outcome of patients with advanced non-small cell lung cancer treated with immune-checkpoint inhibitors. Eur J Cancer. 2021;145:245–254.
  • Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67(6):2089–2100.
  • Islam MM, Valderas JM, Yen L, Dawda P, Jowsey T, McRae IS. Multimorbidity and comorbidity of chronic diseases among the senior Australians: prevalence and patterns. PLoS One. 2014;9(1):e83783.
  • McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66(7):987–994.
  • Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis. 2007;45(3):302–307.
  • Gholam-Mostafaei FS, Yadegar A, Aghdaei HA, Azimirad M, Daryani NE, Zali MR. Anti-TNF containing regimens may be associated with increased risk of Clostridioides difficile infection in patients with underlying inflammatory bowel disease. Curr Res Transl Med. 2020;68(3):125–130.
  • Somagutta MKR, Pormento MKL, Khan MA, et al. The Efficacy of vitamin C, thiamine, and corticosteroid therapy in adult sepsis patients: a systematic review and meta-analysis. Acute Crit Care. 2021;36(3):185–200.
  • Na SJ, Ha TS, Koh Y, et al. Characteristics and clinical outcomes of critically ill cancer patients admitted to Korean intensive care units. Acute Crit Care. 2018;33(3):121–129.
  • Jasiak NM, Alaniz C, Rao K, Veltman K, Nagel JL. Recurrent Clostridium difficile infection in intensive care unit patients. Am J Infect Control. 2016;44(1):36–40.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.